Form 4: Centene Director Christopher J. Coughlin Reports Changes in Beneficial Ownership

Director Christopher J. Coughlin reports acquisition of restricted stock units and adjustments to beneficial ownership of Centene Corp stock.

Summary

• On May 14, 2024, Christopher J. Coughlin, a director of Centene Corp, reported changes in beneficial ownership.
• He acquired 2,916 shares of restricted stock units at $0.
• These restricted stock units will vest on the earlier of May 14, 2025, or the date of Centene's next annual meeting of stockholders.
• Following the transaction, Coughlin directly owns 25,503.926 shares of common stock.
• He also holds options to buy 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, to February 7, 2032.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a company director. The acquisition of restricted stock units can be seen as a slightly positive sign, indicating confidence in the company's future.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment to the company's success.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• The vesting schedules and exercise prices are typical for such equity-based compensation plans.
• Comparing the size of the equity grants and ownership percentages to those of peers in the managed care industry (e.g., UnitedHealth Group, Anthem, Humana) would provide further context.

Stakeholder Impact

• Shareholders may view the acquisition of restricted stock units by a director as a positive sign, aligning management's interests with their own.
• The filing provides transparency regarding insider transactions, which is important for maintaining investor confidence.

Key Dates